What is going on at Global Cord Blood Corp?
An article written by Frances Verter from Parent's Guide to Cord Blood and CEO of CordSavings Didier Nouziès.
Click here to read the article.
Cordsavings SA Route de l'Ile-au-Bois 1A CH-1820 Monthey
- T : +41 24 471 40 00
- F : +41 24 471 91 40
- info@cordsavings.ch
- Home
- News
CordSavings - COVID-19
The last US study which proves pregnant women must not delay COVID-19 vaccination ***
For further information:
Faced with the COVID-19 pandemic, the entire CordSavings team remains fully committed and operational in Monthey.
Our CordSavings laboratory is 100% rooted in its region in Switzerland.
It is one of the last laboratories in Switzerland to have complete know-how that allows it to handle everything locally: both the isolation of precious stem cells from your child’s cord blood and their storage in tanks in liquid nitrogen vapour phase for up to several decades.
This major COVID-19 health crisis and the disarray it has caused worldwide within the medical community as a whole, demonstrates how important it is to develop and strengthen other treatment options in the future.
Among these, the use of stem cells will no doubt play an increasingly key role, if not a major one.
Read this article, for example:
Compassionate use of stem cell therapy to treat severe COVID-19 could save lives now
The collection of your own cells, those of your family, that is to say by definition those that are the most genetically compatible, is more important now than ever.
They could even be decisive one day.
During this period of such uncertainty and fear, and as you get ready to have a baby on top of it, please do not hesitate to call Jeanne, Hélène or Jean-Christophe at any time on +41 24 471 40 00
CSG-BIO communiqué: Bankrupted Cryo-Save Stem Cells inventory security – a decisive step
Geneva and Monthey: Februrary 11, 2020 – CSG-BIO SA (CSG-Bio), which intends to offer the most advancedand comprehensive stem cell banking services to families worldwide in the near future and took over some of CryoSave AG’s assets in 2019 has now announced the signing of an agreement with CORDSAVINGS SA (CordSavings), the reputed independent Swiss neonatal stem cells laboratory, in the aim to secure part of stem cell samples left in insecurity following the bankruptcy of the Swiss company Cryo-Save AG in September 2019.
Disabilities: the differences that make our everyday heroes
CORDSAVINGS is joining forces with the information campaign on the inclusion of people with disabilities.
Using stem cells from the blood or the tissue of the umbilical cord, it is possible to treat certain diseases and regenerate certain tissues.
This is a conviction we have shared since 2012, in the most direct and concrete way possible. By definition, it is the compass that guides our efforts on a daily basis.
Our occupation has something magic and unique about it: with these tiny cells taken from his umbilical cord at birth, without causing any pain, a little new-born brother is able to relieve, treat and perhaps even save his big sister.
And we would know; we have living proof!